Search research articles
Contact Us
Filters
Showing results (51-60 of 124) with videos related to
Page
of 13
Sort By:
Healthcare Management Forum
|
October 25, 2019
Evidence, values, and funding decisions in Canadian cancer systems
Stuart J Peacock, Dean A Regier, Adam J N Raymakers, et al.
Journal of Managed Care & Specialty Pharmacy
|
April 1, 2020
Payer Preferences and Willingness to Pay for Genomic Precision Medicine: A Discrete Choice Experiment
Devender S Dhanda, David L Veenstra, Dean A Regier, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 16, 2014
Parents' willingness to pay for biologic treatments in juvenile idiopathic arthritis
Heather F Burnett, Wendy J Ungar, Dean A Regier, et al.
Arthritis Care & Research
|
April 17, 2012
Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment
Heather F Burnett, Dean A Regier, Brian M Feldman, et al.
Journal of Health Services Research & Policy
|
April 27, 2012
Response to 'Marginal costs of hospital-acquired conditions: information for priority-setting for patient safety programmes and research', Jackson et al., Journal of Health Services Research & Policy 2011;16:141-6
Corneliu Bolbocean, Dean A Regier, Nick Bansback, et al.
CMAJ Open
|
July 29, 2018
Cancer drug expenditure in British Columbia and Saskatchewan: a trend analysis
Reka Pataky, David A Tran, Andrea Coronado, et al.
Pharmacoeconomics
|
January 19, 2021
Early-Phase Clinical Trials and Reimbursement Submissions to the Pan-Canadian Oncology Drug Review
Adam J N Raymakers, Kristina M Jenei, Dean A Regier, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
April 28, 2020
Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication
Samantha Pollard, Steve Kalloger, Deirdre Weymann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2018
Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions
Sarah Wordsworth, Brett Doble, Katherine Payne, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 12, 2020
Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling
Deborah A Marshall, Luiza R Grazziotin, Dean A Regier, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 124) with videos related to
Sort By:
Page
of 13
Healthcare Management Forum
|
October 25, 2019
Evidence, values, and funding decisions in Canadian cancer systems
Stuart J Peacock, Dean A Regier, Adam J N Raymakers, et al.
Journal of Managed Care & Specialty Pharmacy
|
April 1, 2020
Payer Preferences and Willingness to Pay for Genomic Precision Medicine: A Discrete Choice Experiment
Devender S Dhanda, David L Veenstra, Dean A Regier, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
December 16, 2014
Parents' willingness to pay for biologic treatments in juvenile idiopathic arthritis
Heather F Burnett, Wendy J Ungar, Dean A Regier, et al.
Arthritis Care & Research
|
April 17, 2012
Parents' preferences for drug treatments in juvenile idiopathic arthritis: a discrete choice experiment
Heather F Burnett, Dean A Regier, Brian M Feldman, et al.
Journal of Health Services Research & Policy
|
April 27, 2012
Response to 'Marginal costs of hospital-acquired conditions: information for priority-setting for patient safety programmes and research', Jackson et al., Journal of Health Services Research & Policy 2011;16:141-6
Corneliu Bolbocean, Dean A Regier, Nick Bansback, et al.
CMAJ Open
|
July 29, 2018
Cancer drug expenditure in British Columbia and Saskatchewan: a trend analysis
Reka Pataky, David A Tran, Andrea Coronado, et al.
Pharmacoeconomics
|
January 19, 2021
Early-Phase Clinical Trials and Reimbursement Submissions to the Pan-Canadian Oncology Drug Review
Adam J N Raymakers, Kristina M Jenei, Dean A Regier, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
|
April 28, 2020
Genetic testing for hereditary cancer syndromes: patient recommendations for improved risk communication
Samantha Pollard, Steve Kalloger, Deirdre Weymann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2018
Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions
Sarah Wordsworth, Brett Doble, Katherine Payne, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 12, 2020
Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling
Deborah A Marshall, Luiza R Grazziotin, Dean A Regier, et al.
Page
of 13